GA

Galderma Group N (GALD)

HealthcareDrug Manufacturers - Specialty & Generic
169.00CHF
-1.14%
Magic Rank
#23
Earnings Yield
2.2%
Return on Capital
231.7%
Market Cap
38.8B

Performance vs S&P 500 (5Y)

GALD.SW
S&P 500

About Galderma Group N

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Magic Formula Analysis

Enterprise Value40.6B
Market / Universe
ch
Switzerland

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio81.81
Dividend Yield0.3%
Debt to Equity0.23
Gross Margin17.8%